Can Visfatin be Considered as a Diagnostic Marker for Diabetic Nephropathy?
Suzan Tabur, Hakan Korkmaz, Mehmet Ali Eren, Elif Oğuz, Tevfik Sabuncu, Seval Kul, Nurten Aksoy
(Endocrinol Res Pract 2016; 20: 10-15) DOI: 10.4274/tjem.3230
Suzan Tabur, Hakan Korkmaz, Mehmet Ali Eren, Elif Oğuz, Tevfik Sabuncu, Seval Kul, Nurten Aksoy
(Endocrinol Res Pract 2016; 20: 10-15) DOI: 10.4274/tjem.3230
Cavit Çulha, Yavuz Selim Demir, Rüştü Serter, Yalçın Aral
(Endocrinol Res Pract 2010; 14: 35-38)